MENU
+Compare
VYGR
Stock ticker: NASDAQ
AS OF
Aug 11, 12:54 PM (EDT)
Price
$3.12
Change
-$0.02 (-0.64%)
Capitalization
174.17M

VYGR Voyager Therapeutics Forecast, Technical & Fundamental Analysis

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases... Show more

Industry: #Biotechnology
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VYGR with price predictions
Aug 08, 2025

VYGR in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 01, 2025

VYGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where VYGR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where VYGR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for VYGR crossed bullishly above the 50-day moving average on July 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VYGR advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 100 cases where VYGR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VYGR as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VYGR turned negative on August 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

VYGR moved below its 50-day moving average on August 08, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYGR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.714) is normal, around the industry mean (18.662). P/E Ratio (6.318) is within average values for comparable stocks, (54.033). VYGR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (4.294) is also within normal values, averaging (286.048).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VYGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VYGR is expected to report earnings to fall 5.77% to -53 cents per share on November 18

Voyager Therapeutics VYGR Stock Earnings Reports
Q3'25
Est.
$-0.54
Q2'25
Missed
by $0.04
Q1'25
Missed
by $0.08
Q4'24
Missed
by $0.22
Q3'24
Beat
by $0.29
The last earnings report on August 06 showed earnings per share of -56 cents, missing the estimate of -52 cents. With 184.12K shares outstanding, the current market capitalization sits at 174.17M.
A.I. Advisor
published General Information

General Information

a developer of gene therapies for fatal and debilitating diseases of the central nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMOMF0.080.01
+13.29%
Prismo Metals Inc.
MGDDY18.270.08
+0.44%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
BGUUF0.07N/A
N/A
Benguet Corp. BC
EVTZF8.80N/A
N/A
Evertz Technologies Ltd.
YZCFF0.07N/A
N/A
Sinopec Yizheng Chem Fibre Co Ltd

VYGR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-2.48%
RGNX - VYGR
51%
Loosely correlated
-0.63%
KYMR - VYGR
50%
Loosely correlated
-0.56%
TRDA - VYGR
50%
Loosely correlated
-2.08%
XNCR - VYGR
49%
Loosely correlated
-1.23%
IMNM - VYGR
47%
Loosely correlated
-1.82%
More